StockIQpro
NASDAQ:GPCR

Structure Therapeutics Inc.

Track all markets on TradingView
Track all markets on TradingView

Structure Therapeutics Inc. reported net income of −$141.2M in fiscal 2025. Free cash flow was −$225.8M, and the diluted share count rose 12.5%.Summary generated from Structure Therapeutics Inc.'s SEC filings. Latest annual report filed Feb 26, 2026.

Key statistics

Fiscal 2025 from SEC filings. Methodology
Revenue (FY25)n/a
Revenue growthn/a
Revenue, 5-yr CAGRn/a
Gross marginn/a
Operating marginn/a
Net marginn/a
ROICn/a
Return on equity−11.9%
Debt / equityn/a
Free cash flow−$225.8M
FCF marginn/a
Share count change+12.5%

Financials

Fiscal years, $M
Item2022202320242025
Revenuen/an/an/an/a
Operating income−53−103−158−177
Net income−51−90−123−141
Free cash flow−46−82−118−226

Recent filings

From SEC EDGAR

Peers

Pharmaceutical preparations